Non-classical antimetabolites. XI. The bridge principle of specificity with exoalkylating irreversible inhibitors. IV. Highly selective inhibition of the substrateidentical enzyme from two different tissues.
作者： B.R. Baker
DOI: 10.1016/0006-2952(63)90152-7
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(9)
Wallace F. Henion, Earl W. Sutherland, IMMUNOLOGICAL DIFFERENCES OF PHOSPHORYLASES Journal of Biological Chemistry. ,vol. 224, pp. 477- 488 ,(1957) , 10.1016/S0021-9258(18)65046-X
B. R. Baker, William W. Lee, Abelardo P. Martinez, Leonard O. Ross, Leon Goodman, Potential Anticancer Agents. LXXVIII.1 Nonclassical Antimetabolites. IV.2 Synthesis of Compounds Related to 4-(Iodoacetamido)salicylic Acid, an Exo-Alkylating Irreversible Inhibitor Journal of Organic Chemistry. ,vol. 27, pp. 3283- 3295 ,(1962) , 10.1021/JO01056A073
B.R. Baker, R.P. Patel, Non-classical antimetabolites. IX. The bridge principle of specificity with exo-alkylating irreversible inhibitors. III. Detection of differences in specificity of enzymic nucleophilic sites by the carbophenoxy group Biochemical and Biophysical Research Communications. ,vol. 9, pp. 199- 203 ,(1962) , 10.1016/0006-291X(62)90057-8
R. D. Cahn, E. Zwilling, N. O. Kaplan, L. Levine, Nature and Development of Lactic Dehydrogenases: The two major types of this enzyme form molecular hybrids which change in makeup during development. Science. ,vol. 136, pp. 962- 969 ,(1962) , 10.1126/SCIENCE.136.3520.962
B.R. Baker, Non-classical antimetabolites—VIII. The bridge principle of specificity with exo-alkylating irreversible inhibitors Biochemical Pharmacology. ,vol. 11, pp. 1155- 1161 ,(1962) , 10.1016/0006-2952(62)90194-6
T. Wieland, G. Pfleiderer, Isozymes and Heteroenzymes Angewandte Chemie. ,vol. 1, pp. 169- 178 ,(1962) , 10.1002/ANIE.196201691
B. R. Baker, Prabodh I. Almaula, Nonclassical Antimetabolites. X.1,2 A Facile Synthesis of 4-Quinazolone-2-carboxylic Acid and the Structure of Bogert's Ammonium Salt Journal of Organic Chemistry. ,vol. 27, pp. 4672- 4674 ,(1962) , 10.1021/JO01059A524
B. R. Baker, William W. Lee, Ethel Tong, Leonard O. Ross, POTENTIAL ANTICANCER AGENTS.1 LXVI. NON-CLASSICAL ANTIMETABOLITES. III.2 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASE Journal of the American Chemical Society. ,vol. 83, pp. 3713- 3714 ,(1961) , 10.1021/JA01478A034
B. R. Baker, Non-classical Antimetabolites. VII.1,2The Bridge Principle of Specificity with Exo-alkylating Irreversible Inhibitors Journal of Medicinal and Pharmaceutical Chemistry. ,vol. 5, pp. 654- 656 ,(1962) , 10.1021/JM01238A028